ColgatePalmolive (CL)
(Delayed Data from NYSE)
$90.49 USD
-0.52 (-0.57%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $90.50 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$90.49 USD
-0.52 (-0.57%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $90.50 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
Zacks News
Colgate-Palmolive (CL) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Colgate-Palmolive (CL) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Colgate-Palmolive (CL) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 2.35% and 1.06%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Here's How Clorox (CLX) is Placed Just Ahead of Q2 Earnings
by Zacks Equity Research
Clorox's (CLX) Q2 results are expected to reflect gains from solid demand, cost-saving efforts, strong execution and pricing actions. Its IGNITE strategy and digital investments bode well.
3 Reasons Why Growth Investors Shouldn't Overlook Colgate-Palmolive (CL)
by Zacks Equity Research
Colgate-Palmolive (CL) could produce exceptional returns because of its solid growth attributes.
The Zacks Analyst Blog Highlights Alphabet, Salesforce, Comcast, Colgate-Palmolive and American Water Works
by Zacks Equity Research
Alphabet, Salesforce, Comcast, Colgate-Palmolive and American Water Works are included in this Analyst Blog.
Colgate-Palmolive (CL) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Get a deeper insight into the potential performance of Colgate-Palmolive (CL) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Procter & Gamble (PG) Beats Q2 Earnings Estimates, Ups EPS View
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results reflect robust pricing, along with growth across all segments. All its business segments have seen growth in organic sales.
The Zacks Analyst Blog Highlights Alphabet, Salesforce, Comcast, Colgate-Palmolive and American Water Works
by Zacks Equity Research
Alphabet, Salesforce, Comcast, Colgate-Palmolive and American Water Works are part of the Zacks top Analyst Blog.
Colgate (CL) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Colgate's (CL) fourth-quarter 2023 performance is likely to have gained from solid consumer demand and efforts related to innovation, premiumization and digital transformation.
Top Stock Reports for Alphabet, Salesforce & Comcast
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Salesforce, Inc. (CRM) and Comcast Corporation (CMCSA).
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Solid Brand Portfolio to Aid Procter & Gamble's (PG) Q2 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results are expected to reflect the benefits of a robust brand portfolio, cost-saving and productivity measures, and effective business strategies, offset by elevated costs.
Colgate-Palmolive (CL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Stocks Set to Grow in the Thriving Soap & Cleaning Materials Industry
by Rajani Lohia
The soap and cleaning materials industry looks poised for growth on favorable demand trends, pricing efforts, innovation, digital transformation and brand building amid elevated costs. Players like PG, CL, CHD and CLX look well-poised.
5 Large-Cap Stocks Set to Beat on Earnings Next Week
by Nalak Das
We have narrowed our search to five large-cap stocks that are poised to beat on earnings results next week. These are: NFLX, CL, PKG, APH, BAH.
Procter & Gamble (PG) Strong Brands Aid Growth Amid Inflation
by Zacks Equity Research
Procter & Gamble (PG) is navigating market challenges and leveraging growth opportunities in fiscal 2024, showcasing robust sales in key divisions and innovative ventures like Ninjamas.
Newell (NWL) Poised for Growth, Unveils Strategic Realignment
by Zacks Equity Research
Newell (NWL) announces strategic realignment to strengthen commercial capabilities and drive operational efficiencies. The company expects to cut the workforce under the plan.
Here's Why Colgate-Palmolive (CL) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Consumer Staples Stocks Lagging ColgatePalmolive (CL) This Year?
by Zacks Equity Research
Here is how Colgate-Palmolive (CL) and Campbell Soup (CPB) have performed compared to their sector so far this year.
Will Colgate-Palmolive (CL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Lamb Weston (LW) Q2 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Lamb Weston's (LW) second-quarter fiscal 2024 performance is likely to reflect benefits from effective pricing and a solid operating momentum. Capacity expansion efforts are also an upside.
What's in Store for Constellation Brands' (STZ) Q3 Earnings?
by Zacks Equity Research
Constellation Brands' (STZ) Q3 results are expected to reflect strength in the beer business and gains from the premiumization strategy.
Conagra Brands (CAG) Q2 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Conagra Brands' (CAG) second-quarter results are likely to reflect volume concerns due to the industry-wide slowdown in consumption, whereas strength in brands is likely to have been an upside.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.